Alcon and RxSight announced a nonexclusive collaboration to develop a light-adjustable presbyopia-correcting IOL, according to a press release.“This collaboration will enable surgeons to fine-tune visual outcomes for their cataract patients who choose a PCIOL, which is not an available option today,” Ron Kurtz, MD, president and CEO of RxSight, told Healio.The collaboration aims to combine RxSight’s postoperative light-adjustable technology with…
Source: Healio News
